Hataya Poonyagariyagorn

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Angiotensin receptor blockade attenuates cigarette smoke–induced lung injury and rescues lung architecture in mice

Megan Podowski, Carla L. Calvi, Shana Metzger et al. · Journal of Clinical Investigation · 2011 · 131 citations · Full text

Veterinary Medicine, Pathobiology, Pharmacology +17

Challenges in the diagnosis and management of <i>Nocardia</i> infections in lung transplant recipients

Hataya Poonyagariyagorn, Ari Gershman, Robin K. Avery et al. · Transplant Infectious Disease · 2008 · 70 citations

Medicine, Immunology, Infectious Diseases +16

Role of aromatization in anticipatory and consummatory aspects of sexual behavior in male rats

Charles E. Roselli, Ericha Cross, Hataya Poonyagariyagorn et al. · Hormones and Behavior · 2003 · 55 citations

Life Sciences, Behavioral Sciences, Neuroscience +15

Superoxide Dismutase 3 Dysregulation in a Murine Model of Neonatal Lung Injury

Hataya Poonyagariyagorn, Shana Metzger, Dustin Dikeman et al. · American Journal of Respiratory Cell and Molecular Biology · 2014 · 32 citations · Full text

Life Sciences, Pathobiology, Physiology +17